Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4Phase 2/3 1Phase 1 1

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

NETWORK 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 5

Interventions

Prednisone 53Radiotherapy 52Docetaxel 51Leuprolide 48Goserelin 47bicalutamide 45enzalutamide 28acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 27Androgen Antagonists 27Flutamide 24Triptorelin Pamoate 22apalutamide 18Gonadotropin-Releasing Hormone 18Abiraterone Acetate 17Radiation 15abiraterone 14Zoledronic Acid 14Magnetic Resonance Spectroscopy 13gallium 68 PSMA-11 12Prednisolone 11luprolide acetate gel depot 10darolutamide 9Radiosurgery 9cabazitaxel 8Standard of Care 8Specimen Handling 8Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 8Estramustine 8Dexamethasone 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Prostatic Neoplasms × nilutamide × Clear all
NCT03678025 2025-09-11

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

SWOG Cancer Research Network

Phase 3 Recruiting
1,273 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003653 2021-06-23

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
1,386 enrolled
Genitourinary

Prostatic Neoplasms

NCT00002633 2020-04-03

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
361 enrolled
Genitourinary

Prostatic Neoplasms

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Completed
306 enrolled
Genitourinary

Prostatic Neoplasms

NCT00175396 2014-03-17

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

University of British Columbia

Phase 3 Unknown
400 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡